Abstract
Current diagnostic imaging tools cannot differentiate lethal plaques in atherosclerosis, and are not sensitive enough for preventive medicine. On page 367 M. Tirrell and co-workers present monocyte-targeting, peptide amphiphile micelles as a new class of diagnostic agents for molecular imaging capable of discriminating between varying stages of atherosclerosis. Bio-distribution and clearance mechanisms are investigated in vivo. Cover image by Peter Allen.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
